Levodopa + Carbidopa Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg
Reference Brands: Sinemet®(US & EU); Rytary®, Parcopa®, Duodopa®
Category:
Antipsychotropic Drugs
Levodopa-Carbidopa treats Parkinson’s disease, available in 100/25 mg, 250/25 mg, and 200/50 mg tablets. Brands include Sinemet®, Rytary®, and Duodopa®. Pharma B2B platforms enable global sourcing from GMP-certified manufacturers, ensuring regulatory-compliant, high-quality bulk supply for hospitals, pharmacies, and neurology care providers
Levodopa + Carbidopa is available in Tablets
and strengths such as IR: 100 mg/25 mg , 250 mg/25 mg; ER: 200 mg/50 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Levodopa + Carbidopa is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Levodopa + Carbidopa can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Levodopa-Carbidopa is a first-line treatment for Parkinson’s disease, available in various oral formulations including immediate-release, extended-release, and orally disintegrating tablets. It is also supplied as Duodopa® intestinal gel for advanced stages. Common strengths include 100/25 mg, 250/25 mg, and 200/50 mg. Leading brands include Sinemet®, Rytary®, and Duodopa® in both the US and EU markets. Levodopa restores dopamine, while Carbidopa enhances its CNS availability and reduces side effects. Pharma B2B marketplaces connect global buyers with GMP-compliant manufacturers of Levodopa-Carbidopa, offering regulatory-compliant, bulk supply solutions for hospitals, distributors, and neurology-focused pharma procurement.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing